With the announcement from the Costa Rican Social Security Fund (CCSS) that the second study of the application of equine serum in Covid-19 patients is soon to begin, the scientists in charge prepare the modifications for these new tests, among which is adjusting the dose according to the patient’s weight.
According to Alberto Alape, researcher for the Clodomiro Picado Institute of the University of Costa Rica (UCR), the study involves four groups of patients who will receive different doses.
“In the first trial, a single dose was given. Some patients responded well, and in others, the medication had no effect,” Alape explained. “One interpretation of the results is that the patients were of very different characteristics; there were some of more than 150 kg and others of 60 kg, so the same dose for the patients was diluted in the patient’s mass and did not have the same result. In conclusion, for the second study, the dose will be adjusted according to the patient’s w